BVF Inc
- SEC CIK
- 0001056807
- 最新申報
- 2026/8/14
2021 年第 3 季持倉
持倉截至 2021/9/30，2021/11/15 申報。只含多頭部位，變化是跟 2021 年第 2 季比股數。
- 持股檔數
- 75
- 較 2021 年第 2 季 +5
- 總值
- $25.6 億
- 較 2021 年第 2 季 −$1.05 億 (−3.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| GHRSGH Research PLC | ORDINARY SHARES | 9,275,158 | $2.05 億 | 8.0% | +20.0% | 加碼 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 3,180,658 | $1.87 億 | 7.3% | +550,000+20.9% | 加碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 6,661,503 | $1.84 億 | 7.2% | 00.0% | 不變 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 3,229,822 | $1.13 億 | 4.4% | +432,000+15.4% | 加碼 | 歷史 |
| Merus N VN5749R900 | CALL | 5,060,071 | $1.11 億 | 4.3% | +5,060,071 | 新進 | – |
| ARGXArgenx SE | SPONSORED ADR | 366,204 | $1.11 億 | 4.3% | −285,000−43.8% | 減碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 3,722,398 | $9,768 萬 | 3.8% | 00.0% | 不變 | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 3,530,543 | $8,738 萬 | 3.4% | 00.0% | 不變 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 3,901,759 | $6,914 萬 | 2.7% | +147,664+3.9% | 加碼 | 歷史 |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 14,360,000 | $6,907 萬 | 2.7% | +5,966,000+71.1% | 加碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 2,485,049 | $6,836 萬 | 2.7% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 2,049,113 | $6,461 萬 | 2.5% | −889,089−30.3% | 減碼 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 1,119,733 | $5,891 萬 | 2.3% | +1,119,733 | 新進 | 歷史 |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 11,407,182 | $5,818 萬 | 2.3% | +9,691,201+564.8% | 加碼 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 2,005,862 | $5,410 萬 | 2.1% | 00.0% | 不變 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,486,429 | $4,752 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| ACIUAC Immune SA | SHS | 6,935,179 | $4,654 萬 | 1.8% | −1,610,000−18.8% | 減碼 | 歷史 |
| VSTMVerastem, Inc. | COM | 14,977,258 | $4,613 萬 | 1.8% | +3,691,000+32.7% | 加碼 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 2,957,807 | $4,425 萬 | 1.7% | +1,011,858+52.0% | 加碼 | – |
| WHWKWhitehawk Therapeutics, Inc. | COM | 1,147,052 | $3,369 萬 | 1.3% | +1,147,052 | 新進 | 歷史 |
| SPROSpero Therapeutics, Inc. | COM | 1,809,352 | $3,331 萬 | 1.3% | −328,626−15.4% | 減碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 1,635,112 | $3,063 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 1,694,933 | $2,981 萬 | 1.2% | +1,694,933 | 新進 | 歷史 |
| INFIInfinity Pharmaceuticals, Inc. | COM | 8,383,645 | $2,867 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| Pieris Pharmaceuticals Inc720795103 | COM | 5,328,239 | $2,755 萬 | 1.1% | 00.0% | 不變 | – |
| REPLReplimune Group, Inc. | COM | 926,529 | $2,746 萬 | 1.1% | +7,601+0.8% | 加碼 | 歷史 |
| CTICCti Biopharma Corp | COM | 8,929,690 | $2,634 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| VIRXViracta Therapeutics, Inc. | COM | 3,094,174 | $2,482 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 1,373,044 | $2,472 萬 | 1.0% | +373,044+37.3% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 1,571,778 | $2,402 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| IMAImageneBio, Inc. | COM | 1,832,071 | $2,312 萬 | 0.9% | +64,672+3.7% | 加碼 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 2,851,461 | $2,281 萬 | 0.9% | +399,900+16.3% | 加碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 6,631,051 | $2,228 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 1,017,314 | $2,201 萬 | 0.9% | −159,367−13.5% | 減碼 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 2,772,226 | $2,132 萬 | 0.8% | +2,772,226 | 新進 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 9,544,262 | $2,090 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 953,879 | $2,008 萬 | 0.8% | +929,599+3,828.7% | 加碼 | 歷史 |
| NGMNGM Biopharmaceuticals Inc | COM | 955,000 | $2,007 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 810,284 | $1,923 萬 | 0.8% | −108,691−11.8% | 減碼 | 歷史 |
| MTEMMolecular Templates, Inc. | COM | 2,856,599 | $1,917 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,589,495 | $1,696 萬 | 0.7% | +1,589,495 | 新進 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 735,106 | $1,659 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| GRTSGritstone bio, Inc. | COM | 1,528,072 | $1,650 萬 | 0.6% | −298,422−16.3% | 減碼 | 歷史 |
| CALACalithera Biosciences, Inc. | COM | 7,452,331 | $1,625 萬 | 0.6% | +153,000+2.1% | 加碼 | 歷史 |
| Calliditas Therapeutics AB13124Q106 | SPONSERED ADS | 750,000 | $1,622 萬 | 0.6% | 00.0% | 不變 | – |
| CFRXCONTRAFECT Corp | COM NEW | 3,972,300 | $1,609 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 826,825 | $1,562 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 666,666 | $1,441 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 804,126 | $1,323 萬 | 0.5% | +454,045+129.7% | 加碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,532,282 | $1,289 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 1,590,298 | $1,239 萬 | 0.5% | +70.0% | 加碼 | 歷史 |
| CDTXCidara Therapeutics, Inc. | COM | 4,776,904 | $1,070 萬 | 0.4% | +430,000+9.9% | 加碼 | 歷史 |
| ELTXElicio Therapeutics, Inc. | COM | 1,071,297 | $1,047 萬 | 0.4% | +34,797+3.4% | 加碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 448,512 | $1,011 萬 | 0.4% | +448,512 | 新進 | 歷史 |
| LITSLite Strategy, Inc. | COM NEW | 3,532,057 | $974.8 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ANABAnaptysbio, Inc | COM | 334,398 | $906.9 萬 | 0.4% | −474,312−58.7% | 減碼 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 435,936 | $868.4 萬 | 0.3% | +435,936 | 新進 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,363,435 | $842.6 萬 | 0.3% | +250,000+22.5% | 加碼 | 歷史 |
| MOLNMolecular Partners AG | ADS | 419,008 | $826.7 萬 | 0.3% | +419,008 | 新進 | 歷史 |
| IVAInventiva S.A. | ADS | 544,500 | $770.5 萬 | 0.3% | +437,500+408.9% | 加碼 | 歷史 |
| GNCAGenocea Biosciences, Inc. | COM NEW | 4,012,404 | $770.4 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| Erytech Pharma29604W108 | SPONSORED ADR | 1,314,656 | $758.6 萬 | 0.3% | 00.0% | 不變 | – |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 1,370,947 | $663.5 萬 | 0.3% | −2,307,679−62.7% | 減碼 | 歷史 |
| RNTXRein Therapeutics, Inc. | COM | 5,265,555 | $537.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| EOCNGalmed Pharmaceuticals Ltd. | SHS | 1,799,694 | $502.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Eucrates Biomedical Acqu CorG3141W114 | UNIT 10/23/2027 | 500,000 | $495.5 萬 | 0.2% | 00.0% | 不變 | – |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 500,000 | $493.0 萬 | 0.2% | 00.0% | 不變 | – |
| 5 01 Acquisition Corp33836P105 | COM CL A | 500,000 | $490.0 萬 | 0.2% | 00.0% | 不變 | – |
| RACBResearch Alliance Corp. II | COM CL A | 500,000 | $483.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 847,879 | $448.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 289,663 | $430.4 萬 | 0.2% | +289,663 | 新進 | 歷史 |
| Forward Pharma A/S34986J204 | SPONSORD ADS NEW | 432,892 | $298.7 萬 | 0.1% | −95,622−18.1% | 減碼 | – |
| JYACJiya Acquisition Corp. | COM CL A | 300,000 | $293.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 190,815 | $141.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM | 319,678 | $133.0 萬 | 0.1% | −1,373,778−81.1% | 減碼 | 歷史 |
2021 年第 2 季之後清倉（5 檔）
2021 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 2 季股數 | 2021 年第 2 季市值 | 2021 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| MRUSMerus N.V. | COM | 7,285,071 | $1.53 億 | 5.8% | 歷史 |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 2,772,226 | $2,850 萬 | 1.1% | – |
| FBRXForte Biosciences, Inc. | COM | 591,811 | $1,990 萬 | 0.7% | 歷史 |
| IMVTImmunovant, Inc. | COM | 1,273,516 | $1,346 萬 | 0.5% | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 58,900 | $130.8 萬 | <0.1% | 歷史 |